Global Medical Unit Head, IBD & Life Cycle Management, Zasocitinib

By clicking the “Apply” button, I understand that my employment application process with Takeda will commence and that the information I provide in my application will be processed in line with Takeda’s Privacy Notice and Terms of Use. I further attest that all information I submit in my employment application is true to the best of my knowledge.

Job Description

Primary Accountabilities:

• Leads development and execution of multi-year global medical strategy for the TAK-279 (Zasocitinib) IBD, New indications and LCM, appropriately aligned with overall asset strategy and GPT, incorporating various functional strategies across functions in R&D and Global Portfolio Division (Clinical, Medical, Regulatory, Global Evidence and Outcome (GEO), PV, Global Product Launch Strategy (GPLS), Marketing and Commercial Excellence (MCE), and the countries/LOCs).
• Serves as the global scientific expert within Takeda in support of TAK-279 (Zasocitinib) IBD, New indications and LCM .
• Leads the Medical Strategy Team (MST) TAK-279 (Zasocitinib) IBD, New indications and LCM.
• Responsible for development execution of Global Medical plans and collaboration with the counties/LOCs as appropriate.
• Develop and manage the Global Medical budget.
• Acts as a senior company representative interacting with external scientific leaders, patient advocacy groups and/or regulatory authorities.
• Establishes appropriate strategic partnerships with centers of excellence, patient organizations, and expert HCPs for TAK-279 (Zasocitinib) IBD, and new indications.
• Collaborates with Legal, Ethics, Compliance and Regulatory functions to ensure appropriate interactions between Global Medical personnel and external stakeholders.

Key Responsibilities:

Defines GM strategy and plans:

• Leads development of multi-year medical strategy forTAK-279 (Zasocitinib) IBD, New indications and LCM, publications strategy, congress strategy, customer interaction strategy, the scientific communication platform for the disease area / brand(s) aligned with product strategy, BD medical activities and digital strategy.
• Oversees development of in-year medical tactical plan and budget for the global initiatives
• Leads functional (e.g. publications, medical communications, medical training) and in-line teams in developing plans supporting Global Medical strategy.
• Leads the collaboration with commercial/GPLS/MCE to ensure aligned and medically appropriate commercial strategy, planning and execution.
• Participates in development of product strategy; co-creates with Product Strategy Teams and GPTs.
• Develops and defines GM team goals and key performance metrics.

Leads the Medical Strategy Teams (MST):

• Collaborates with Legal, Ethics, Compliance, Regulatory and Medical Training to ensure understanding and adherence of GM team to Takeda and external policies and regulations.
• Coordinates with the Head, Global Immunology TA, MSTs, and MEST to define and address global medical team training and professional development needs as well as training needs related to the product/disease area.
• Mentor, coach, and develop Global Medical team.
• Monitor team performance and identify areas for development.

Oversees and manages in-year implementation of GM strategy, potentially including:

• Providing physician leadership for scientific communications and evidence generation strategy, including standard responses and publications.
• Planning, designing, and managing global advisory boards and collaborating with regional and LOC activities.
• Providing medical review and approval of Investigator Initiated Research (IIR) proposals and other grants through the grant approval process.
• Leading design and execution of clinical studies with Global Medical Evidence (phase IIIb/IV, disease registries, epidemiological studies, outcomes surveys, etc.) in close collaboration with R&D func